JP2023536509A5 - - Google Patents
Info
- Publication number
- JP2023536509A5 JP2023536509A5 JP2023508083A JP2023508083A JP2023536509A5 JP 2023536509 A5 JP2023536509 A5 JP 2023536509A5 JP 2023508083 A JP2023508083 A JP 2023508083A JP 2023508083 A JP2023508083 A JP 2023508083A JP 2023536509 A5 JP2023536509 A5 JP 2023536509A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- trifluoromethyl
- bis
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010779964.6 | 2020-08-05 | ||
| CN202010779964 | 2020-08-05 | ||
| PCT/CN2021/110506 WO2022028459A1 (en) | 2020-08-05 | 2021-08-04 | Pharmaceutical composition of aquaporin inhibitor and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023536509A JP2023536509A (ja) | 2023-08-25 |
| JP2023536509A5 true JP2023536509A5 (https=) | 2024-08-06 |
Family
ID=80120008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023508083A Pending JP2023536509A (ja) | 2020-08-05 | 2021-08-04 | アクアポリン阻害剤の医薬組成物およびその製造方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230293556A1 (https=) |
| EP (1) | EP4192442A4 (https=) |
| JP (1) | JP2023536509A (https=) |
| KR (1) | KR20230137284A (https=) |
| CN (1) | CN117337182A (https=) |
| AU (1) | AU2021323181A1 (https=) |
| BR (1) | BR112023002129A2 (https=) |
| CA (1) | CA3187716A1 (https=) |
| IL (1) | IL300341A (https=) |
| MX (1) | MX2023001493A (https=) |
| TW (1) | TW202228714A (https=) |
| WO (1) | WO2022028459A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013169939A2 (en) | 2012-05-08 | 2013-11-14 | Aeromics, Llc | New methods |
| US20160279155A1 (en) | 2013-11-06 | 2016-09-29 | Aeromics, Inc. | Novel formulations |
| US11117909B2 (en) | 2016-05-13 | 2021-09-14 | Aeromics, Inc. | Crystals |
| WO2024208207A1 (zh) * | 2023-04-03 | 2024-10-10 | 拜西欧斯（北京）生物技术有限公司 | 一种双取代萘化合物及其药物组合物和用途 |
| WO2025075479A1 (ko) * | 2023-10-04 | 2025-04-10 | 이화여자대학교 산학협력단 | 아쿠아포린 4 억제제의 심방세동 치료 용도 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2488363C (en) * | 2002-06-06 | 2011-01-04 | Institute Of Medicinal Molecular Design, Inc. | O-substituted hydroxyaryl derivatives |
| WO2008067196A2 (en) * | 2006-11-16 | 2008-06-05 | The Regents Of The University Of California | Methods for identifying inhibitors of solute transporters |
| WO2013169939A2 (en) * | 2012-05-08 | 2013-11-14 | Aeromics, Llc | New methods |
| US20160279155A1 (en) * | 2013-11-06 | 2016-09-29 | Aeromics, Inc. | Novel formulations |
| CA2931550C (en) * | 2013-12-13 | 2023-09-26 | Vertex Pharmaceuticals Incorporated | Prodrugs of pyridone amides useful as modulators of sodium channels |
| US11117909B2 (en) * | 2016-05-13 | 2021-09-14 | Aeromics, Inc. | Crystals |
-
2021
- 2021-08-04 EP EP21852147.4A patent/EP4192442A4/en active Pending
- 2021-08-04 AU AU2021323181A patent/AU2021323181A1/en active Pending
- 2021-08-04 US US18/040,618 patent/US20230293556A1/en active Pending
- 2021-08-04 CA CA3187716A patent/CA3187716A1/en active Pending
- 2021-08-04 IL IL300341A patent/IL300341A/en unknown
- 2021-08-04 BR BR112023002129A patent/BR112023002129A2/pt unknown
- 2021-08-04 CN CN202180057413.1A patent/CN117337182A/zh active Pending
- 2021-08-04 JP JP2023508083A patent/JP2023536509A/ja active Pending
- 2021-08-04 WO PCT/CN2021/110506 patent/WO2022028459A1/en not_active Ceased
- 2021-08-04 MX MX2023001493A patent/MX2023001493A/es unknown
- 2021-08-04 KR KR1020237007248A patent/KR20230137284A/ko active Pending
- 2021-08-05 TW TW110128921A patent/TW202228714A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023536509A5 (https=) | ||
| JP7475395B2 (ja) | 異常な新生血管形成を伴う眼疾患を処置するためにニンテダニブを使用する組成物および方法 | |
| CA2814371C (en) | Use of malononitrilamides in neuropathic pain | |
| KR20120013404A (ko) | 화상 치료 조성물 및 방법 | |
| JP2023512763A5 (https=) | ||
| JP2022533981A5 (https=) | ||
| WO2025118014A1 (en) | A composition containing a carboxamide redox derivative compound as an active ingredient for the prevention or treatment of arthritis | |
| KR20200036920A (ko) | 행동 변경 치료 방법 | |
| JP7224687B2 (ja) | 局所注射用組成物 | |
| JP2025142200A (ja) | ダプトマイシン製剤 | |
| DD298478A5 (de) | Verwendung eines heteroaryl-3-oxo-propannitrilderivats und pharmazeutisches praeparat zur behandlung von auroimmunerkrankungen | |
| JP6960415B2 (ja) | 三叉神経痛を予防又は治療する目的のためのカルバメート化合物の使用 | |
| JP2025134747A5 (https=) | ||
| US20240382455A1 (en) | Composition containing 1h-pyrazole-3-amide-based compound derivative for prevention or treatment of fibrosis | |
| WO2011149012A1 (ja) | イソキノリンスルホニル誘導体を有効成分として含有する網脈絡膜変性疾患の予防または治療剤、網脈絡膜変性疾患の予防または治療方法、イソキノリンスルホニル誘導体またはその医薬的に許容される塩、ならびにその使用 | |
| WO2024139978A1 (zh) | Vofopitant用于治疗肺纤维化的用途 | |
| TWI590827B (zh) | 以組合透明質酸及黃素腺嘌呤二核苷酸為特徵的角膜上皮細胞死亡抑制劑 | |
| EA008145B1 (ru) | Инъецируемая галеновая форма флупиртина | |
| CN111494370B (zh) | Pyr3在制备保护肝损伤的药物中的应用 | |
| CN107496426A (zh) | 含伊马替尼或其药学上可接受的盐作为有效成分的用于治疗或预防血管渗透性疾病的组合物 | |
| JP2024524933A5 (https=) | ||
| JP6907174B2 (ja) | アミロイド線維形成の抑制又は阻害剤 | |
| AU2016364380B2 (en) | Formulations for intravenous injection of danirixin | |
| TW202122089A (zh) | 肥大細胞疾病及嗜酸性病症之治療 | |
| JP4374085B2 (ja) | 虚血再潅流性脳障害軽減剤 |